Emmes exists to provide its clients with the skill sets, technologies, and dedicated service required to manage clinical research studies. As a CRO we embrace your goals and manage your clinical research as if it were our own. To help you conduct research that meets the highest standards of quality, we apply a unique toolkit of clinical research professionals, advanced technologies, and decades of global clinical research experience.

Whether you require a full service CRO or a functional outsourcing relationship, Emmes welcomes the opportunity to collaborate with you.

Clinical Research Services

Our mission involves searching for truth in human health issues through the design of high quality research studies. The integrity of research remains our highest priority, and we bring a solid statistical approach to every phase of your clinical study, including protocol development, study design, site/investigator recruitment and management, data collection/management, statistical analysis, regulatory filing, and publications.


Emmes biostatisticians partner with you to improve your study’s performance from initial planning through data analysis and reporting. Our shared goal is to optimize your trial, data quality and study results.


Our Bioinformatics solutions combine state-of-the-art statistical methodology with information technologies to process, analyze and integrate large-scale clinical research data.

Advantage eClinical

Advantage eClinical is Emmes’ clinical trials electronic data capture platform. Co-developed by IT and data management professionals, biostatisticians, clinicians, medical officers, programmers and analysts at Emmes, Advantage eClinical provides users a full suite of eclinical technologies to manage studies from early trial planning through close of study.

Real World Data and Real World Evidence

Clinical research that effectively combines clinical trial data with real world evidence (RWE) of drug effectiveness, safety, or variability across subpopulations has become essential in supporting drug development and regulatory submissions.